Through GO and KEGG analyses, we further identified that C5aR1 was associated with Alzheimer’s disease-related pathways and tumor development-related pathways, e.g., the MAPK signaling cascade. This evidence concerns the gene C5AR1 and early-onset autosomal dominant Alzheimer disease.